Vitality Watch

Dossier pubmed preclinical 31-jul-2026
Animal model, organoid, or cell-culture result — not yet human

From antioxidant to senotherapeutic: Repurposing n-acetylcysteine to counteract senescence via the HuR pathway in human endothelial cells.

Key claim: N-acetylcysteine counteracts replicative senescence hallmarks in human endothelial cells by restoring the HuR–MnSOD/HSP70 axis and lowering ROS, p21, and inflammatory cytokines.

Abstract

Cellular senescence plays a dual role in physiology and pathology. While it contributes to tumour suppression and tissue repair, its persistence promotes chronic inflammation, tissue dysfunction, and age-related diseases. Oxidative stress is a major driver of this process, and the RNA-binding protein HuR serves as a regulator by stabilizing transcripts encoding antioxidant and stress-response proteins. In this study, we established an in vitro model of replicative senescence using human umbilical vein endothelial cells (HUVECs) and investigated the potential anti-aging effects of N-acetylcysteine (NAC), an antioxidant and glutathione precursor. Late-passage HUVECs exhibited a senescent phenotype, including enlarged morphology, increased senescence-associated (SA)-β-galactosidase activity, elevated reactive oxygen species (ROS) levels, and upregulation of p16 and p21 proteins. We observed a progressive decline in HuR expression from early to late passages. NAC treatment counteracted these hallmarks, significantly decreasing ROS and p21 levels. Notably, NAC restored HuR expression and its protective targets, MnSOD and HSP70, and reduced inflammatory markers (IL-6 and TNF-α) levels. These findings suggest that the decline of the HuR-protective axis is a critical driver of endothelial senescence and demonstrate that NAC can mitigate aging hallmarks, representing a promising therapeutic strategy to target aging-related dysfunctions.

Why this matters

N-acetylcysteine counteracts replicative senescence hallmarks in human endothelial cells by restoring the HuR–MnSOD/HSP70 axis and lowering ROS, p21, and inflammatory cytokines.

Source

Link

Briefing card

From antioxidant to senotherapeutic: Repurposing n-acetylcysteine to counteract senescence via the HuR pathway in human endothelial cells.
Stage: preclinical · pubmed · 31-jul-2026

N-acetylcysteine counteracts replicative senescence hallmarks in human endothelial cells by restoring the HuR–MnSOD/HSP70 axis and lowering ROS, p21, and inflammatory cytokines.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.exger.2026.113257

build build 880 · 2bcef25 · 2026-11-18